Status:
COMPLETED
Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Lead Sponsor:
Johns Hopkins University
Conditions:
Conjunctivitis
SARS-CoV-2
Eligibility:
All Genders
18+ years
Brief Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly identified, highly contagious RNA virus causing respiratory infectious disease, Coronavirus Disease 2019 (COVID-19). Conjunctivi...
Eligibility Criteria
Inclusion
- Age 18 years old or older
- Willingness to participate
- Presents with red eye complaint
Exclusion
- Adults lacking capacity to consent
- Adults with special needs due to physical, medical, developmental or cognitive conditions
Key Trial Info
Start Date :
May 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 29 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04374656
Start Date
May 18 2020
End Date
May 29 2024
Last Update
May 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilmer Eye Institute
Baltimore, Maryland, United States, 21287